Von Hippel Lindau Disease

PIs: Sven Glaesker and Vera Van Velthoven

 

To ameliorate the treatment of VHL we perform clinical and basic scientific research on the disease. Our project “Molecular Mechanisms of Tumorigenesis in von Hippel-Lindau Disease” is supported by a research grant from the “Fonds Wetenschappelijk Onderzoek” (FWO) Vlaanderen. In this research project we investigate tumor tissue of VHL patients to identify targets for medical treatment. The project starts in October 2016 and is supported for 5 years.